IRIS
CITRARO, Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.095
AS - Asia 2.204
EU - Europa 1.530
SA - Sud America 540
AF - Africa 56
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 8
Totale 7.464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.886
SG - Singapore 970
IT - Italia 649
CN - Cina 465
BR - Brasile 427
DE - Germania 265
VN - Vietnam 262
IN - India 230
CA - Canada 169
FI - Finlandia 145
GB - Regno Unito 138
SE - Svezia 111
HK - Hong Kong 58
AR - Argentina 41
NL - Olanda 35
ID - Indonesia 30
AU - Australia 29
MX - Messico 28
JP - Giappone 27
TR - Turchia 26
RU - Federazione Russa 25
ES - Italia 22
EC - Ecuador 21
FR - Francia 19
CO - Colombia 18
IQ - Iraq 18
UA - Ucraina 18
ZA - Sudafrica 18
BD - Bangladesh 17
PL - Polonia 14
CZ - Repubblica Ceca 12
IL - Israele 12
PK - Pakistan 12
GR - Grecia 11
IR - Iran 11
RO - Romania 11
CL - Cile 9
UZ - Uzbekistan 9
AT - Austria 8
CH - Svizzera 8
SA - Arabia Saudita 8
VE - Venezuela 8
KR - Corea 7
MA - Marocco 7
MT - Malta 7
EG - Egitto 6
PY - Paraguay 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AE - Emirati Arabi Uniti 5
EE - Estonia 5
KE - Kenya 5
PH - Filippine 5
PT - Portogallo 5
BG - Bulgaria 4
HR - Croazia 4
NG - Nigeria 4
PE - Perù 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
AF - Afghanistan, Repubblica islamica di 3
AO - Angola 3
EU - Europa 3
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
MY - Malesia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BO - Bolivia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GA - Gabon 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
RS - Serbia 2
SC - Seychelles 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
ET - Etiopia 1
GD - Grenada 1
GH - Ghana 1
HU - Ungheria 1
IE - Irlanda 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PW - Palau 1
Totale 7.462
Salva come PNG Salva come JPEG
Città #
Chandler 430
Singapore 404
Dallas 337
Munich 230
Santa Clara 179
Bengaluru 169
Hefei 166
Milan 147
Princeton 128
Ashburn 127
Lawrence 127
Catanzaro 116
Ottawa 99
Ho Chi Minh City 96
London 87
Wilmington 75
Beijing 72
Chicago 72
Turku 69
Helsinki 67
Hong Kong 54
Hanoi 50
Boardman 47
Des Moines 44
New York 41
São Paulo 41
Los Angeles 39
Redwood City 31
Brooklyn 26
Montreal 22
Tokyo 22
Haiphong 18
Shanghai 17
Guangzhou 16
Rome 16
Palermo 15
Boston 14
Norwalk 14
Rio de Janeiro 14
Toronto 14
Florence 13
Johannesburg 13
Melbourne 13
San Nicola Manfredi 13
Shenzhen 12
The Dalles 12
Warsaw 12
Amsterdam 11
Atlanta 11
Council Bluffs 11
Da Nang 11
Olomouc 11
Istanbul 10
Messina 10
Phoenix 10
Stockholm 10
Bari 9
Mexico City 9
Brasília 8
Hải Dương 8
Naples 8
Padova 8
Pune 8
Salvador 8
San Francisco 8
Tashkent 8
West Jordan 8
Ankara 7
Aversa 7
Boydton 7
Chennai 7
Columbus 7
Curinga 7
Curitiba 7
Guayaquil 7
Prato 7
San Jose 7
Vienna 7
Assago 6
Augusta 6
Belo Horizonte 6
Bogotá 6
Bắc Giang 6
Campinas 6
Can Tho 6
Cosenza 6
Falls Church 6
Houston 6
Madrid 6
Newark 6
Nuremberg 6
Porto Alegre 6
Sydney 6
Tel Aviv 6
Teresina 6
Thái Bình 6
Vancouver 6
Bauru 5
Biên Hòa 5
Casalnuovo di Napoli 5
Totale 4.231
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 235
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 157
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 121
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 89
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 89
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 86
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 86
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 85
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 82
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 79
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 75
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 70
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 69
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 68
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 68
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 68
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 67
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 67
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 67
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 65
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 64
3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents 64
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 64
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 63
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 63
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 63
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 61
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 60
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 60
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 60
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 60
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 60
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 59
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 59
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 59
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 57
Pharmacokinetic considerations about antiseizure medications in the elderly 57
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 56
Alpha-lactoalbumin, a whey protein rich in tryptophan, is effective in rodent models of seizures and epileptogenesis 56
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 56
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis 55
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy 55
Bioinspired Electric Stimulation: Comparison of ECoG Spectrum in the Main Auditory Structures 55
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 54
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 54
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 54
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation  54
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 54
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells (CO-FIRST AUTHOR) 54
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes 52
A questionnaire-based study on prevalence and treatments of headache in Secondary Schools people of Catanzaro 52
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 52
Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP 51
Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis 51
Microbiota-gut brain axis involvement in neuropsychiatric disorders 51
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 51
Epidemiology and outcomes of status epilepticus 50
Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures. Expert Opin Pharmacother. 2014 Jan 17. [Epub ahead of print] PubMed PMID: 24437529. 49
Immediate and controlled-release pregabalin for the treatment of epilepsy 49
Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence 49
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 49
Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats 49
Vasostatin-1 restores autistic disorders in an idiopathic autism model (BTBR T+ Itpr3tf/J mice) by decreasing hippocampal neuroinflammation 48
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 47
The potential role of cannabinoids in epilepsy treatment. 46
Biomimetic Sonar for Electrical Activation of the Auditory Pathway 46
Nano‐hydrogel embedded with quercetin and oleic acid as a new formulation in the treatment of diabetic foot ulcer: A pilot study 46
Corrigendum to "Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice)" (DOI:10.1016/j.neuropharm.2005.04.012) 46
Colchicine in Managing Skin Conditions: A Systematic Review 46
A Multiple Synergic Treatment for Non-Healing Ulcer Management in a Patient with Klippel–Trenaunay Syndrome 45
Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. 45
Pharmacovigilance in pharmaceutical companies: An overview 45
Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 45
Comparative Analysis of the Treatment of Chronic Antipsychotic Drugs on Epileptic Susceptibility in Genetically Epilepsy-prone Rats 45
Statins and Epilepsy: Preclinical Studies, Clinical Trials and Statin-Anticonvulsant Drug Interactions 45
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 44
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region 44
Antidepressants drugs for seizures and epilepsy: Where do we stand? 44
Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis 44
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 43
Long-Term High-Fat Diet Aggravates Absence Seizures and Neurobehavioral Disorders Without Inducing Metabolic Disorders in WAG/Rij Rats: Involvement of Systemic and Central Inflammation 43
Assessing Gender Differences in Neuropathic Pain Management: Findings from a Real-Life Clinical Cross-Sectional Observational Study 43
Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis 43
Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists 43
Can we ‘seize’ the gut microbiota to treat epilepsy? 43
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy 43
mTOR inhibition modulates epileptogenesis, seizures and depressive-like behavior in a genetic model of absence seizures and mild depression comorbidity: a role for inflammatory responses 42
Direct Modulation of High-Frequency Neural Oscillations in the Auditory Cortex Through Electrical Microstimulation Generated by PVDF Sensors 42
Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment 42
Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy 41
Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity 41
Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDs 41
Are big potassium-type Ca2+-activated potassium channels a viable target for the treatment of epilepsy? 41
Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis 41
Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease 40
Long-term betamethasone 21-phosphate disodium treatment has distinct effects in CD1 and DBA/2 mice on animal behavior accompanied by opposite effects on neurogenesis 40
Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG/Rij rats, a genetic animal model of absence epilepsy 40
An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy 40
An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists 39
Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders 39
Totale 5.779
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.485
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021265 0 0 0 0 0 145 42 9 38 11 15 5
2021/2022431 3 6 9 91 21 14 6 83 79 50 57 12
2022/20231.224 261 101 41 102 119 98 14 79 191 86 91 41
2023/2024729 120 89 63 59 54 120 31 46 11 47 29 60
2024/20252.139 261 71 104 88 142 267 162 93 236 69 265 381
2025/20262.625 304 448 557 673 513 130 0 0 0 0 0 0
Totale 7.721